BARAZZONI, ROCCO
 Distribuzione geografica
Continente #
NA - Nord America 15.509
EU - Europa 9.237
AS - Asia 5.355
SA - Sud America 1.328
AF - Africa 147
OC - Oceania 101
Continente sconosciuto - Info sul continente non disponibili 24
Totale 31.701
Nazione #
US - Stati Uniti d'America 14.959
PL - Polonia 2.136
CN - Cina 2.017
IT - Italia 2.017
SE - Svezia 992
BR - Brasile 834
UA - Ucraina 819
SG - Singapore 799
JP - Giappone 558
HK - Hong Kong 553
TR - Turchia 518
DE - Germania 500
ES - Italia 438
MX - Messico 417
FI - Finlandia 311
RU - Federazione Russa 277
BG - Bulgaria 228
GB - Regno Unito 222
IE - Irlanda 215
ID - Indonesia 198
CH - Svizzera 189
FR - Francia 178
IN - India 141
AR - Argentina 133
CO - Colombia 122
NL - Olanda 119
VN - Vietnam 118
PT - Portogallo 105
BE - Belgio 103
GR - Grecia 100
CA - Canada 90
TW - Taiwan 86
AU - Australia 83
CL - Cile 79
IL - Israele 74
PE - Perù 66
KR - Corea 61
TH - Thailandia 52
EC - Ecuador 42
MY - Malesia 39
SI - Slovenia 37
DK - Danimarca 35
NO - Norvegia 35
RO - Romania 34
AT - Austria 32
EG - Egitto 28
IR - Iran 26
SN - Senegal 26
HU - Ungheria 25
PH - Filippine 25
SA - Arabia Saudita 25
CZ - Repubblica Ceca 19
NZ - Nuova Zelanda 18
VE - Venezuela 18
TN - Tunisia 17
EU - Europa 16
PY - Paraguay 16
AE - Emirati Arabi Uniti 15
HR - Croazia 15
CR - Costa Rica 14
BO - Bolivia 13
RS - Serbia 13
ZA - Sudafrica 11
SK - Slovacchia (Repubblica Slovacca) 10
A2 - ???statistics.table.value.countryCode.A2??? 8
NG - Nigeria 8
DZ - Algeria 7
EE - Estonia 7
ET - Etiopia 7
LT - Lituania 7
MD - Moldavia 7
PA - Panama 7
BD - Bangladesh 6
LV - Lettonia 6
MA - Marocco 6
NP - Nepal 6
PK - Pakistan 6
HN - Honduras 5
LB - Libano 5
SV - El Salvador 5
ZM - Zambia 5
AF - Afghanistan, Repubblica islamica di 4
BB - Barbados 4
SD - Sudan 4
BF - Burkina Faso 3
CD - Congo 3
CM - Camerun 3
CU - Cuba 3
CY - Cipro 3
GH - Ghana 3
IS - Islanda 3
KZ - Kazakistan 3
LK - Sri Lanka 3
PR - Porto Rico 3
RW - Ruanda 3
TZ - Tanzania 3
UY - Uruguay 3
UZ - Uzbekistan 3
AO - Angola 2
AZ - Azerbaigian 2
Totale 31.677
Città #
Warsaw 2.026
Woodbridge 1.971
Fairfield 1.759
Houston 1.384
Ann Arbor 1.342
Ashburn 1.009
Chandler 1.004
Wilmington 842
Jacksonville 774
Seattle 754
Singapore 657
Cambridge 582
Hong Kong 523
Trieste 501
Boardman 407
Princeton 346
Beijing 272
Columbus 245
Izmir 239
Sofia 227
Dublin 202
Moscow 161
São Paulo 143
Shanghai 137
Milan 134
Madrid 130
Rome 120
Dearborn 114
Tokyo 105
Bern 103
Istanbul 96
San Diego 93
Guangzhou 90
Redmond 86
Santa Clara 86
Rio de Janeiro 67
Grafing 63
Ankara 60
Barcelona 58
Nanjing 54
Chicago 52
Los Angeles 52
Athens 50
Brussels 50
Buenos Aires 49
Chengdu 49
Santiago 49
Lima 48
Hangzhou 47
Bogotá 45
Falls Church 45
Lisbon 44
Salvador 44
Jinan 43
Jakarta 42
Brasília 41
Medellín 41
Hefei 40
Helsinki 40
Chongqing 39
Naples 39
Hanoi 38
Amsterdam 37
Bangkok 37
Des Moines 37
Tel Aviv 37
Xi'an 36
Dong Ket 34
Ho Chi Minh City 34
Mexico City 33
Florence 32
Taipei 32
Bologna 31
Guadalajara 31
Pune 30
Valencia 30
Phoenix 29
Washington 29
Belo Horizonte 28
Fortaleza 28
Frankfurt am Main 28
Osaka 28
Redwood City 28
Curitiba 27
Paris 27
Shenyang 27
Stockholm 27
Sydney 27
Toronto 27
Wuhan 27
Dakar 26
Dallas 26
Norwalk 26
Kunming 25
Ljubljana 24
Munich 24
Turin 24
Venice 24
Verona 24
Berlin 23
Totale 21.057
Nome #
ESPEN guidelines on definitions and terminology of clinical nutrition 2.189
GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community 1.946
Could ketogenic diet "starve" cancer? Emerging evidence 714
Nutritional status and the risk of malnutrition in older adults with chronic kidney disease – implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN 711
Diagnostic criteria for malnutrition - An ESPEN Consensus Statement 658
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition (GLIM) diagnosis of malnutrition 468
AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia 403
Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet-induced hyperglycemia and whole-body insulin resistance in rodents 387
Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall 337
GLIM Criteria for the Diagnosis of Malnutrition: A Consensus Report From the Global Clinical Nutrition Community 334
Update on the impact of omega 3 fatty acids on inflammation, insulin resistance and sarcopenia: A review 325
Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo 320
Lack of Fibronectin Extra Domain A Alternative Splicing Exacerbates Endothelial Dysfunction in Diabetes 308
Omega 3 Polyunsaturated Fatty Acids Improve Endothelial Dysfunction in Chronic Renal Failure: Role of eNOS Activation and of Oxidative Stress 293
Nutritional status and physical inactivity in moderated asthmatics: A pilot study 280
Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review 278
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure 277
Tuberculosis and malnutrition: The European perspective 264
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction 249
Poor nutritional status but not cognitive or functional impairment per se independently predict 1 year mortality in elderly patients with hip-fracture 247
Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals 227
Sarcopenic Obesity: Time to Meet the Challenge 227
Unacylated ghrelin improves vascular dysfunction and attenuates atherosclerosis during high-fat diet consumption in rodents 224
Nutrition in Renal Disease 210
Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome. 209
Towards a multidisciplinary approach to understand and manage obesity and related diseases 205
Decreased VLDL-Apo B 100 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy 202
Insulin resistance in obesity: an overview of fundamental alterations 202
High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle. 199
Acylated Ghrelin Limits Fat Accumulation and Improves Redox State and Inflammation Markers in the Liver of High-Fat-Fed Rats. 196
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 188
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in Rome November 2022 184
Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group 179
Treatment with n-3 Polyunsaturated Fatty Acids Reverses Endothelial Dysfunction and Oxidative Stress in Experimental Menopause 178
Nutrition education in medical schools (NEMS). An ESPEN position paper 172
Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition diagnosis of malnutrition 171
Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease 169
A negative impact of recent weight loss on in-hospital mortality is not modified by overweight and obesity 160
Effectiveness and efficacy of nutritional therapy: a systematic review following Cochrane methodology 159
Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers 156
null 155
Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. 153
Standard operating procedures for ESPEN guidelines and consensus papers 153
null 152
Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group 151
Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance 149
Sarcopenic obesity: What about in the cancer setting? 142
Exposure to artificial light at night: A common link for obesity and cancer? 141
Fighting protein-energy wasting in chronic kidney disease: a challenge of complexity. 140
Ghrelin forms in the modulation of energy balance and metabolism 139
The role of substrates in the regulation of protein metabolism. 138
null 138
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. 135
null 135
Hyperglucagonemia stimulates phenylalanine oxidation in humans. 135
Evidence for acute stimulation of fibrinogen production by glucagon in humans 135
Protein degradation and synthesis measured with multiple amino acid tracers in vivo. 135
null 134
null 134
Acute Infusion of N-3 Polyunsaturated (N-3 PUFA) Fatty Acids is not Associated with Enhanced Reactive Oxygen Species Generation and Lowers Mitochondrial ATP Production in Rat Liver 134
Time-dependent changes in plasma total, acylated and desacylated ghrelin after gastric by-pass 133
null 132
Sarcopenic obesity: Time to meet the challenge 132
Protein metabolism in glucagonoma. 130
A model of skeletal muscle leucine kinetics measured across the human forearm. 129
Clinical nutrition university: Muscle physiology and bioenergetics 129
null 128
Effects of branched-chain-enriched amino acids and insulin on forearm leucine kinetics. 128
n-3-Pufa Dietary Enrichment Improves Whole-Body Insulin Action and Normalizes Muscle Mass, Mitochondrial Function, Oxidative Stress, and Insulin Signalling in Experimental Uremia 127
null 125
null 123
null 121
null 121
null 121
Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis. 121
Perioperative nutritional support. 120
null 119
null 119
null 118
null 118
Differential Cross-Sectional and Prospective Predictive Value for Insulin Resistance of Different Anthropometric Indexes and Parameters in A North-East Italy Community-Based Population Cohort 117
Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis 116
Differences in estimates of forearm protein synthesis between leucine and phenylalanine tracers following unbalanced amino acid infusion. 115
null 115
null 114
Mechanisms of postprandial protein accretion in human skeletal muscle. Insight from leucine and phenylalanine forearm kinetics. 114
Effect of insulin sensitizer therapy on amino acids and their metabolites 114
Obesity: focus on ongoing multidisciplinary and comprehensive research 114
null 113
null 113
null 113
Protein metabolism in Type 1 and Type 2 diabetes mellitus in the fasted and fed states 113
null 112
null 112
Unacylated Ghrelin Normalizes Oxidative Stress and Insulin Action in Rat Muscle and Prevents Muscle Loss in Experimental Uremia 112
null 111
Intravenous lipid infusion and total plasma fatty acids positively modulate plasma acylated ghrelin in vivo 109
null 107
Relationships between phenylalanine hydroxylation and plasma aromatic amino acid concentrations in humans. 107
Negative association between plasma desacylated Ghrelin and carotid artery intima-media thickness in females with the Metabolic Syndrome 107
Totale 22.375
Categoria #
all - tutte 83.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.986 0 0 0 0 0 649 526 479 413 246 363 310
2020/20213.297 334 194 260 342 331 325 195 383 185 346 121 281
2021/20222.208 75 169 143 167 68 219 93 93 256 250 197 478
2022/20233.136 278 335 223 446 276 554 56 229 357 43 276 63
2023/20244.137 242 159 157 125 169 238 344 396 17 228 974 1.088
2024/20257.757 1.019 1.083 1.371 1.534 1.640 1.110 0 0 0 0 0 0
Totale 32.642